Danaher DHR-PB Stock
Danaher Price Chart
Danaher DHR-PB Financial and Trading Overview
Danaher stock price | 1261.26 USD |
Previous Close | 1271.2 USD |
Open | 1263.9 USD |
Bid | 0 USD x 900 |
Ask | 0 USD x 900 |
Day's Range | 1260.39 - 1265.99 USD |
52 Week Range | 1199.99 - 1521.85 USD |
Volume | 152.33K USD |
Avg. Volume | 12.97K USD |
Market Cap | N/A |
Beta (5Y Monthly) | 0.80173 |
PE Ratio (TTM) | 146.01297 |
EPS (TTM) | 0 USD |
Forward Dividend & Yield | 50 (3.93%) |
Ex-Dividend Date | March 30, 2023 |
1y Target Est | N/A |
DHR-PB Valuation Measures
Enterprise Value | 935.34B USD |
Trailing P/E | 146.01297 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | 18.97345 |
Enterprise Value/Revenue | 29.721 |
Enterprise Value/EBITDA | 85.311 |
Trading Information
Danaher Stock Price History
Beta (5Y Monthly) | 0.80173 |
52-Week Change | -7.85% |
S&P500 52-Week Change | 20.43% |
52 Week High | 1521.85 USD |
52 Week Low | 1199.99 USD |
50-Day Moving Average | 1270.85 USD |
200-Day Moving Average | 1362.89 USD |
DHR-PB Share Statistics
Avg. Volume (3 month) | 12.97K USD |
Avg. Daily Volume (10-Days) | 21.01K USD |
Shares Outstanding | N/A |
Float | 649.15M |
Short Ratio | 5.25 |
% Held by Insiders | 0% |
% Held by Institutions | 117.38% |
Shares Short | 78.21K |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 1 |
Trailing Annual Dividend Yield | 0.078% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 22.90% |
Operating Margin (ttm) | 27.77% |
Gross Margin | 60.21% |
EBITDA Margin | 34.83% |
Management Effectiveness
Return on Assets (ttm) | 6.52% |
Return on Equity (ttm) | 15.13% |
Income Statement
Revenue (ttm) | 31.47B USD |
Revenue Per Share (ttm) | 43.4 USD |
Quarterly Revenue Growth (yoy) | 2.70% |
Gross Profit (ttm) | 18.95B USD |
EBITDA | 10.96B USD |
Net Income Avi to Common (ttm) | 7.1B USD |
Diluted EPS (ttm) | 8.638 |
Quarterly Earnings Growth (yoy) | 24.80% |
Balance Sheet
Total Cash (mrq) | 5.99B USD |
Total Cash Per Share (mrq) | 8.23 USD |
Total Debt (mrq) | 20.74B USD |
Total Debt/Equity (mrq) | 41.4 USD |
Current Ratio (mrq) | 1.893 |
Book Value Per Share (mrq) | 66.475 |
Cash Flow Statement
Operating Cash Flow (ttm) | 8.52B USD |
Levered Free Cash Flow (ttm) | 5.59B USD |
Profile of Danaher
Country | United States |
State | DC |
City | Washington |
Address | 2200 Pennsylvania Avenue, North West |
ZIP | 20037-1701 |
Phone | 202 828 0850 |
Website | https://www.danaher.com |
Industry | Diagnostics & Research |
Sector(s) | Healthcare |
Full Time Employees | 79000 |
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, municipal, industrial, and natural resource applications. It also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. The company was founded in 1969 and is headquartered in Washington, the District of Columbia.
Q&A For Danaher Stock
What is a current DHR-PB stock price?
Danaher DHR-PB stock price today per share is 1261.26 USD.
How to purchase Danaher stock?
You can buy DHR-PB shares on the NYSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Danaher?
The stock symbol or ticker of Danaher is DHR-PB.
Which industry does the Danaher company belong to?
The Danaher industry is Diagnostics & Research.
How many shares does Danaher have in circulation?
The max supply of Danaher shares is 0.
What is Danaher Price to Earnings Ratio (PE Ratio)?
Danaher PE Ratio is 0.00000000 now.
What was Danaher earnings per share over the trailing 12 months (TTM)?
Danaher EPS is 0 USD over the trailing 12 months.
Which sector does the Danaher company belong to?
The Danaher sector is Healthcare.